There is growing pressure for robust and economically scalable viral-vector manufacturing technologies.
Mercedes Segura Gally
Advertisement
Mercedes Segura Gally is vice-president of Vector Process Development at ElevateBio.
Articles by Mercedes Segura Gally
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
Why Radiopharmaceuticals Are Ideal for Treating Cancer
2
Check Your Knowledge: Patient-Centric Care Through Oral Liquid Delivery
3
Check Your Knowledge (Answers): Patient-Centric Care Through Oral Liquid Delivery
4
Biopharma’s Digital Hopes Versus Actual Implementation
5
